Thomas Patrick Kelly
CIK 1410514 · Chief Financial Officer · last filed 2025-10-17
Thomas Patrick Kelly is a Chief Financial Officer who has filed 36 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for XENE, was dated Oct 17, 2025. Across all open-market trades the lifetime net is −$6.5M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
36
-$6.53M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XENE | Chief Financial Officer | — | $52.10 | — | $0 | 1 | 2025-10-17 |
| Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Chief Financial Officer | 0 | $25.59 | $0 | -$6.54M | 31 | 2024-06-11 |
| CORNERSTONE THERAPEUTICS INC (CRTX) Delisted | CFO & SVP Finance & Corp. Dev, | 90,700 | $1.95 | $176.9K | $8.3K | 4 | 2008-02-19 |
Recent Filings
36 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-10-17 | XENE | Grant (A) | — | $0 | EDGAR |
| 2024-06-11 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Mixed | −80,350 | $0 | EDGAR |
| 2024-02-20 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Mixed | +14,265 | -$47.0K | EDGAR |
| 2024-01-18 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Sell (S) | −2,435 | -$35.2K | EDGAR |
| 2023-12-14 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Mixed | +5,452 | -$42.9K | EDGAR |
| 2023-10-31 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Mixed | +5,928 | -$27.8K | EDGAR |
| 2023-06-21 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Sell (S) | −1,655 | -$23.8K | EDGAR |
| 2023-02-17 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Mixed | +15,118 | -$20.7K | EDGAR |
| 2023-01-19 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Sell (S) | −2,403 | -$51.0K | EDGAR |
| 2022-06-21 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Sell (S) | −1,768 | -$19.0K | EDGAR |